Honokiol Suppresses Glioma Cell Proliferation by Disrupting SUMO1-YAP1 Conjugation and Promoting YAP1 Proteasomal Degradation
Biomolecules · 10.08.2026 · 16 (8) · 1158
DOI: 10.3390/biom16081158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.08.2026. Verfasst von Zenghua Sheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing 402260, China. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds, Adaptor Proteins, Signal Transducing, Glioma. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Scientific and Technological Research Program of Chongqing Municipal Education Commission.
Abstract (Originalsprache)
Among primary central nervous system malignancies in adults, malignant glioma ranks first in incidence, with glioblastoma (GBM) standing as its most aggressive phenotype. This malignancy remains a devastating disease with limited therapeutic options, largely owing to the intricate network of dysregulated signaling pathways. SUMOylation, a post-translational modification that governs thousands of substrate proteins, is markedly hyperactivated in GBM and represents a rational but underexploited target. Here, we found that honokiol (HNK), a natural biphenolic compound extracted from the traditional Chinese medicine Magnolia species, suppressed SUMOylation in glioma cells, with a more prominent reduction in SUMO1-conjugated species than in SUMO2/3-conjugated species. Through a combination of label-free proteomic screening and functional biological assays, we pinpointed YAP1, a core Hippo pathway effector and established oncogenic driver in glioma cells, as a critical downstream target. Furthermore, our research indicated that inhibition of SUMOylation by HNK was associated with reduced levels of YAP1, resulting in glioma cell growth inhibition. Mechanistically, HNK induced YAP1 ubiquitin–proteasome degradation by disrupting SUMO1-YAP1 conjugation, leading to the subsequent blockade of YAP1 signaling. Collectively, our findings unveiled a previously unrecognized mechanism linking pharmacological deSUMOylation to YAP1 destabilization and emphasized the SUMO–YAP1 interface as a therapeutically actionable vulnerability. Overall, this work provides a strong rationale for developing HNK or its optimized derivatives as a first-in-class therapeutic strategy that addresses the network-level complexity of GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing 402260, China.
ORCID-Profile: Zenghua Sheng, Chunrong Wu, Debing Xiang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Scientific and Technological Research Program of Chongqing Municipal Education Commission
Zitieren
APA
Sheng, Z., Fang, Q., Cui, S., Wang, J., Xiao, H., Wu, C., & Xiang, D. (2026). Honokiol Suppresses Glioma Cell Proliferation by Disrupting SUMO1-YAP1 Conjugation and Promoting YAP1 Proteasomal Degradation. Biomolecules, 16(8), 1158. https://doi.org/10.3390/biom16081158
Vancouver
Sheng Z, Fang Q, Cui S, Wang J, Xiao H, Wu C, et al. Honokiol Suppresses Glioma Cell Proliferation by Disrupting SUMO1-YAP1 Conjugation and Promoting YAP1 Proteasomal Degradation. Biomolecules. 2026;16(8):1158. doi:10.3390/biom16081158
BibTeX
@article{Sheng2026,
author = {Sheng, Zenghua and Fang, Qiaoyun and Cui, Siqian and Wang, Jian and Xiao, Huihui and Wu, Chunrong and Xiang, Debing},
title = {Honokiol Suppresses Glioma Cell Proliferation by Disrupting SUMO1-YAP1 Conjugation and Promoting YAP1 Proteasomal Degradation},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1158},
doi = {10.3390/biom16081158}
}
EUVIMED